Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
Western Australian researchers have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
NEDLANDS, Australia - AussieJournal -- Researchers at the Harry Perkins Institute of Medical Research and The University of Western Australia (UWA) have discovered the genetic cause of a rare muscle disease that causes muscle weakness, droopy eyelids and difficulty swallowing.
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
More on Aussie Journal
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
The disease, known as oculopharyngodistal myopathy (OPDM), is an inherited muscle disease. Genes associated with OPDM had only been identified previously in Asian populations.
This week, Perkins researchers in the Rare Disease Genetics and Functional Genomics Group (https://perkins.org.au/research/labs/genome-bio...), led by Associate Professor Gina Ravenscroft (https://perkins.org.au/person/gina-ravenscroft-2/), and the Preventative Genetics Group (https://perkins.org.au/research/labs/genome-bio...), led by Emeritus Professor Nigel Laing AO, published findings from an international world-leading study that identified the genetic cause of OPDM in people of European descent.
More on Aussie Journal
- Nutrition Tips for Toddlers: Healthy Habits Start Early
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
The researchers discovered that a specific type of mutation, an expansion of a repeat sequence, in the ABCD3 gene triggers a cascade of cellular issues that ultimately leads to muscle degeneration. These repeat expansions have been difficult to pinpoint, but new technologies and computer tools have enabled researchers to more easily find these repeat expansions that cause disease.
"It is so important to study genetic variations across different populations. Discovering that the ABCD3 gene was the cause of OPDM in Europeans adds to the understanding of this disease and opens the door for researchers to explore potential treatments for this and similar muscle diseases," Associate Professor Gina Ravenscroft said.
"Identifying disease-causing genes for families is so rewarding, often families experience these life-changing symptoms and many never get answers about the cause of their disorder. For some families this has ended a very long diagnostic odyssey, with DNA samples first received almost 30 years ago."
More on Aussie Journal
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- Citywide Service Solutions divestment of their NSW, Queensland and ACT (NAQ) Horticulture and Open Space Division
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
There are more than 10,000 distinct rare diseases, 70% of which start in childhood. Most of these diseases have a genetic origin, and families must rely on medical researchers to find the disease-gene needle in their DNA haystack.
"Rare diseases impact around 1 in 10 people and these families can go a lifetime without answers. By finding the genetic cause, we can give families a better understanding of the disease progression, their likelihood of passing it on, and importantly it offers the possibility of finding new treatments or cures one day," Associate Professor Ravenscroft said.
The study was published this week in Nature Communications. (https://www.nature.com/articles/s41467-024-49950-2)
Source: Harry Perkins Institute of Medical Research
0 Comments
Latest on Aussie Journal
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- Perth Author Launches Debut Novel Half Dream, Half Reality — Romance Meets Men's Mental Health
- AXT Supplies Larvotto with Australia's First onsite ECORE LIBS Core Scanning Technology
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- ICHRRF deplores the Hannukah terrorist attack on Jewish community at Bondi Beach, Australia
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- PawHealthAI Gives Australian Breeders First Long-Term Visibility Into Puppy Health Outcomes
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- Launching Oolio Giving: Every tap helps support cancer research
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office